Home
Capstan Therapeutics, Inc.

Capstan Therapeutics, Inc. Market Share Analysis for May 2026

capstan’s mission is to multiply the therapeutic possibilities for patients by developing targeted in vivo rna-based therapies.

Health > Biotechnology and Pharmaceuticals

Domaincapstantx.com

Year Founded2021

Employees51 - 200

Annual Revenue$1M - $2M

Capstan Therapeutics, Inc.

Capstan Therapeutics, Inc. (including company regionals)

capstantx.com

See more website traffic and engagement information

Capstan Therapeutics, Inc. Revenue up to May 2026 is 1M - 2M

revenue generated by Capstan Therapeutics, Inc. top domains

Capstan Therapeutics, Inc. top domains revenue over 3 years

Revenue for Capstan Therapeutics, Inc. top domains

capstantx.com1M - 2M

See more with Sales Intelligence

Total visits to Capstan Therapeutics, Inc.'s top domains

Understand Capstan Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Capstan Therapeutics, Inc.'s top domains

Analyze Capstan Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Capstan Therapeutics, Inc.'s top domains

See how Capstan Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Capstan Therapeutics, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Capstan Therapeutics, Inc.

These are the website technologies, by industry, used by Capstan Therapeutics, Inc. top domains

Widget (3)

Twemoji

Mobile (2)

Meta Viewport

Advertising (1)

DoubleClick

Content Management System (1)

WordPress

More Technologies

8

See all

News & Signals from Capstan Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsShawver left Capstan Therapeutics Inc. as President and Chief Executive Officer on Sep 1st '25.Dr. Shawver most recently served as President and Chief Executive Officer of Capstan Therapeutics (acquired by AbbVie).

NewsCapstan Therapeutics Inc. received financing of $165M in Series A on Jun 30th '21.The AbbVie buyout is a rapid windfall for Capstan, which launched less than four years ago with $165 million in seed and series A fundraising, backed by the venture arms of a host of Big Pharmas, including Pfizer, Bayer, Eli Lilly, Bristol Myers Squibb and Novartis.

NewsAbbVie acquired Capstan Therapeutics Inc. for $2.1B on Feb 1st '25.Under the terms of the agreement, AbbVie will pay up to $2.1 billion in cash at closing to acquire Capstan, subject to certain customary adjustments.